Prognostic value of LC3B and p62 expression in small intestinal adenocarcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jeong-Won | - |
dc.contributor.author | Jun, Sun-Young | - |
dc.contributor.author | Kim, Joon-Mee | - |
dc.contributor.author | Oh, Young-Ha | - |
dc.contributor.author | Yoon, Ghilsuk | - |
dc.contributor.author | Hong, Seung-Mo | - |
dc.contributor.author | Chung, Joon-Yong | - |
dc.date.accessioned | 2022-07-06T11:37:25Z | - |
dc.date.available | 2022-07-06T11:37:25Z | - |
dc.date.created | 2021-12-08 | - |
dc.date.issued | 2021-11 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/140448 | - |
dc.description.abstract | Autophagy, a mechanism that maintains cellular homeostasis, is involved in tumor cell growth and survival in cancer, and autophagy inhibitors have been tested clinical trials for anticancer therapy. To elucidate the clinical and prognostic implications of autophagy in small intestinal adenocarcinoma (SIAC), we assessed the expression of autophagy markers, LC3B and p62, in 171 surgically resected primary SIACs using automated quantitative analysis. Positive LC3B, p62 nuclear (p62Nu), and p62 cytoplasmic (p62Cy) expression was observed in 23 (13.5%), 52 (30.4%), and 43 (25.1%) carcinomas, respectively. LC3B+ expression was correlated with undifferentiated carcinoma (p < 0.001) and high histologic grade (p = 0.029). The combined expression of LC3B and p62Nu (LC3+/p62Nu+) was related to the older age of patients (p = 0.017), undifferentiated carcinoma (p < 0.001), and high grade (p = 0.031). LC3B+ (p = 0.006), p62Cy+ (p = 0.041), or p62Nu+ (p = 0.006) expression were associated with worse survival. In addition, SIAC patients with either LC3B+/p62Nu+ (p = 0.001) or LC3B+/p62Cy+ (p = 0.002) expression had shorter survival times. In multivariate analysis, LC3B expression remained an independent prognostic factor (p = 0.025) for overall survival. In conclusion, autophagy may play a role in the tumorigenesis of SIACs, and LC3B and p62 could be used as prognostic biomarkers and potential therapeutic targets for SIACs. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.title | Prognostic value of LC3B and p62 expression in small intestinal adenocarcinoma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Oh, Young-Ha | - |
dc.identifier.doi | 10.3390/jcm10225398 | - |
dc.identifier.scopusid | 2-s2.0-85119357294 | - |
dc.identifier.wosid | 000726830800001 | - |
dc.identifier.bibliographicCitation | Journal of Clinical Medicine, v.10, no.22, pp.1 - 16 | - |
dc.relation.isPartOf | Journal of Clinical Medicine | - |
dc.citation.title | Journal of Clinical Medicine | - |
dc.citation.volume | 10 | - |
dc.citation.number | 22 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 16 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | SMALL-BOWEL ADENOCARCINOMA | - |
dc.subject.keywordPlus | PROTEIN EXPRESSION | - |
dc.subject.keywordPlus | POOR-PROGNOSIS | - |
dc.subject.keywordPlus | BIOCHEMICAL METHODS | - |
dc.subject.keywordPlus | BECLIN 1 | - |
dc.subject.keywordPlus | AUTOPHAGY | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | OVEREXPRESSION | - |
dc.subject.keywordPlus | PATHOGENESIS | - |
dc.subject.keywordPlus | PROGRESSION | - |
dc.subject.keywordAuthor | Adenocarcinoma | - |
dc.subject.keywordAuthor | LC3B | - |
dc.subject.keywordAuthor | P62 | - |
dc.subject.keywordAuthor | Prognosis | - |
dc.subject.keywordAuthor | Small intestine | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.